Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database

AE related to first-line RA therapies can lead to significant clinical consequences, including treatment discontinuation. Male sex and advanced age were associated with increased AE severity. The most affected systems appear consistent with known drug safety profiles, particularly that of methotrexate; however, the absence of information regarding drug dosage precludes more detailed conclusions. These findings emphasize the need for individualized monitoring strategies and improved pharmacovigilance to optimize long-term treatment safety and adherence in RA management.

Authors

Institutions

Publication Details

Journal
ARP Rheumatology
Published
2025-12-30
DOI
https://doi.org/10.63032/xqfs6110
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database

Ana Cláudia Raposo, João Dias, Luís Inês, Ana Águeda et al.
ARP Rheumatology
Rheumatoid Arthritis Research and Therapies
article

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database

Ana Cláudia Raposo, João Dias, Luís Inês, Ana Águeda, Ana Catarina Moniz, Patrícia Nero, Daniel Carvalho, Maria Francisca Magalhães, Ana Vilar, Ana Valido, Teresa Pinho e Melo, M S Bernardes, Helena Assunção, Carla Campinho Ferreia, Mourão Am, Cláudia Miguel, Manuel Morgado, Inês Sopa, Mariana Emília Santos, Helena Santos, Mariana Diz Lopes, Susana Almeida, Pedro Pereira, Ana Cristina Cordeiro, Marina Oliveira, Susana Emídio Matias, Maria Pontes Ferreira, Catarina R Rua, Duarte Augusto, Carlos Marques Gomes, Daniel Melim, Catarina Abreu, Filipe Pinheiro, João Lagoas Gomes, Ana Teodósio Chícharo, Joana Ramos Rodrigues, Rita Fonseca, José Tavares-Costa, Margarida Oliveira, Leonor Reynolds, Filipa Canhão André, Joaquim Polido Pereira, Marília Rodrigues, Filipe Araújo, José António Pereira Silva, Maura Couto, Luís Silva Pires, Ana Rita Vieira, Vítor Silvestre Teixeira, Pedro Miguel Teixeira, Sara Alves Costa, Graça Sequeira, João Aguiar, Filipa Farinha, Anita Cunha, Catarina Silva, Maria Helena Lourenço, Jorge Garcia, Ana Catarina Duarte, Cátia Duarte
article en

Abstract

AE related to first-line RA therapies can lead to significant clinical consequences, including treatment discontinuation. Male sex and advanced age were associated with increased AE severity. The most affected systems appear consistent with known drug safety profiles, particularly that of methotrexate; however, the absence of information regarding drug dosage precludes more detailed conclusions. These findings emphasize the need for individualized monitoring strategies and improved pharmacovigilance to optimize long-term treatment safety and adherence in RA management.

ARP RheumatologyVol. 4(4)
University of Trás-os-Montes and Alto Douro (PT), Hospitais da Universidade de Coimbra (PT), Hospital Center of Cova da Beira (PT), Hospital de São João (PT), Instituto Superior de Espinho (PT), Universidade Politécnica da Guarda (PT), Hospital de Egas Moniz (PT), Administração Regional de Saúde de Lisboa e Vale do Tejo (PT), Instituto Politécnico de Santarém (PT), Hospital do Divino Espírito Santo (PT), Centro Hospitalar do Tâmega e Sousa (PT), Instituto Português de Malacologia (PT), Centro Hospitalar de Lisboa Ocidental (PT), Santa Casa de Misericórdia de Marília (BR), National Laboratory for Civil Engineering (PT), Regione del Veneto (IT), Secretaria da Saúde (BR), Hospital Braga (PT), Hospital Garcia de Orta (PT), Hospital de Santa Maria (PT), Centro Hospitalar do Porto (PT), Escola Secundária de Loulé (PT), Cognitive Research (United States) (US), Hospital do Desterro (PT), Hospital Dr. Nélio Mendonça (PT), Hospital CUF Descobertas, Instituto Português de Reumatologia, University of Aveiro (PT), University of Coimbra (PT)
Good health and well-being
Openalex Percentile: Top 26%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.